VYST.OQBVystar CORP
10-K: Vystar Corporation Reports Increased Revenue but Continues to Face Losses in 2023
Sentiment:
Annual Report
Vystar Corporation's 2023 annual report reveals a significant increase in revenue, but the company still faces substantial net losses and going concern challenges.
Capital raiseThe company plans to finance its operations through private placements, indicating a potential capital raise.The company's reliance on stock issuances to new and existing shareholders suggests a need for additional capital.
Worse than expectedThe company's net loss increased significantly compared to the previous year, indicating worsening financial performance.The company's cash position is very low, and it has a significant working capital deficit, raising concerns about its ability to meet its financial obligations.The company's accumulated deficit has increased, indicating a history of financial challenges that are not being resolved.The report includes a statement that there is substantial doubt about the company's ability to continue as a going concern, which is a clear indication of worse than expected results.
Summary
- Vystar Corporation reported a substantial increase in revenue for the year ended December 31, 2023, reaching $525,883, a 351.3% increase compared to $116,533 in 2022.
- The company's gross profit improved significantly, moving from a loss of $388,692 in 2022 to a profit of $384,583 in 2023.
- Operating expenses decreased by 24.8%, from $2,558,708 in 2022 to $1,924,552 in 2023, primarily due to a reduction in impairment losses.
- Despite the revenue increase and reduced operating expenses, Vystar reported a net loss of $8,319,395 for 2023, compared to a net loss of $4,331,155 in 2022.
- The company's accumulated deficit reached $60,612,738 by the end of 2023.
- Vystar's cash position at the end of 2023 was $35,442, with a working capital deficit of $5,422,880.
- The company plans to finance its operations through cash on hand, private placements, and increased sales of RxAir products.
- There is substantial doubt about the company's ability to continue as a going concern due to its history of losses and financial condition.
Sentiment
Score: 3
Explanation: The document presents a mixed picture with a significant increase in revenue but also substantial net losses and a going concern warning. The overall sentiment is negative due to the company's financial instability and uncertain future.
Positives
- Vystar experienced a significant increase in revenue, indicating growing market traction for its products.
- The company's gross profit improved substantially, suggesting better cost management and pricing strategies.
- Operating expenses were reduced, reflecting efforts to control costs and improve efficiency.
- Vystar has a distribution network for sales of RX400 and RX800 units to the healthcare and medical markets.
- The company is actively collaborating to develop new applications for its Vytex technology, including green tires and biodegradable products.
Negatives
- Vystar continues to incur significant net losses, raising concerns about its long-term financial viability.
- The company has a substantial accumulated deficit, indicating a history of financial challenges.
- Vystar's cash position is very low, and it has a significant working capital deficit.
- There is substantial doubt about the company's ability to continue as a going concern.
- The company is dependent on third-party producers, which exposes it to operational risks.
- The latex market is competitive, and Vystar faces challenges from synthetic alternatives.
Risks
- Vystar's ability to achieve profitability is uncertain, and it may continue to incur significant losses.
- The company's reliance on third-party producers exposes it to risks related to supply chain disruptions and quality control issues.
- The latex market is competitive, and Vystar faces challenges from synthetic alternatives and new market entrants.
- Fluctuations in commodity prices for natural rubber latex could adversely affect Vystar's revenue and profitability.
- The company's ability to utilize tax losses could be limited if it experiences an ownership change.
- Vystar's stock price may be volatile due to factors beyond its control, and investors could lose all or part of their investment.
- The company's dependence on key employees and the potential loss of such employees could disrupt its business.
Future Outlook
Vystar plans to finance future operations using cash on hand, increased revenue from RxAir air purifier sales and Vytex license fees, and stock issuances. The company also plans to restart production of the RX3000 unit and begin production of the RX300 unit in 2024. There is no assurance that the company will be able to achieve projected levels of revenue in 2024 and beyond.
Management Comments
- Management plans to finance future operations using cash on hand, as well as increased revenue from RxAir air purifier sales and Vytex license fees.
- Management believes the lack of a functioning audit committee results in ineffective oversight in the establishment and monitoring of required internal controls and procedures, which could result in a material misstatement in our financial statements in future period.
- Management expects to strengthen internal control during 2024 by developing stronger business and financial processes for accounting for transactions such as warrant/stock issuances, which will enhance internal control for the Company.
Industry Context
The report highlights Vystar's position in the competitive air purification and natural rubber latex markets. The company is leveraging its patented technologies to address growing demand for eco-friendly and health-focused products. The report also notes the impact of the COVID-19 pandemic on the natural rubber supply chain and the increased consumer awareness of airborne disease transmission, which has driven demand for air purifiers.
Comparison to Industry Standards
- Vystar's financial performance is weak compared to established companies in the air purification and latex industries. Companies like Honeywell and 3M in air purification, and major latex producers like Sri Trang Agro-Industry and Halcyon Agri, typically have much stronger revenue and profitability.
- Vystar's reliance on third-party manufacturers is a common practice in the industry, but its financial instability makes it more vulnerable to supply chain disruptions than larger, more financially stable competitors.
- The company's focus on patented technologies and eco-friendly products aligns with industry trends, but its ability to scale production and achieve profitability remains a challenge.
- Vystar's net loss and negative cash flow are significantly worse than industry averages for companies of similar size and stage of development. Many companies in the same sector are either profitable or have a clear path to profitability with strong financial backing.
- The company's accumulated deficit and going concern issues are not typical for established companies in the air purification and latex industries, indicating significant financial challenges.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer | Steven Rotman | Jamie Rotman | 2023-12-21 | Resignation of Steven Rotman |
| President | Steven Rotman | Jamie Rotman | 2023-12-21 | Resignation of Steven Rotman |
| Chief Financial Officer | Steven Rotman | Jamie Rotman | 2023-12-21 | Resignation of Steven Rotman |
Legal Proceedings
- Vystar is involved in ongoing litigation with EMA Financial, Inc., related to a convertible promissory note and stock purchase agreement. The court ruled in Vystar's favor, but EMA has filed an appeal.
- The company is awaiting a court decision on legal and expert fees related to the EMA Financial litigation.
Related Party Transactions
- Vystar has significant related party transactions with Steven Rotman, Gregory Rotman, and Jamie Rotman, including employment agreements, consulting agreements, and advances.
- Blue Oar Consulting, Inc., owned by Gregory Rotman, provides business consulting services to Vystar.
- Dr. Bryan Stone receives a commission for RxAir units sold to a specific customer.
Stakeholder Impact
- Shareholders face significant risks due to the company's financial instability and potential for stock price volatility.
- Employees may be affected by potential cost-cutting measures or restructuring due to the company's financial challenges.
- Customers may be impacted by potential supply chain disruptions or changes in product availability.
- Suppliers may face risks related to payment delays or potential contract terminations.
- Creditors face risks related to the company's ability to repay its debts.
Next Steps
- Vystar plans to increase sales of RxAir air purifiers and Vytex license fees.
- The company intends to restart production of the RX3000 unit and begin production of the RX300 unit in 2024.
- Management plans to strengthen internal controls and improve financial processes.
- The company will continue to seek additional financing through private placements and stock issuances.
Key Dates
| Date | Description |
|---|---|
| 2000-02-01 | Vystar LLC was formed as a Georgia limited liability company. |
| 2003-01-01 | Vystar Corporation was incorporated in Georgia. |
| 2004-12-31 | Vystar adopted a stock option plan. |
| 2008-11-01 | RxAir400 product was cleared by the FDA as a Class II medical device. |
| 2009-04-01 | Vystar's Board of Directors authorized an increase in the number of shares to be issued under the stock option plan. |
| 2013-05-01 | Vystar began a private placement offering to sell Series A Cumulative Convertible Preferred Stock. |
| 2018-04-01 | Vystar acquired the assets of NHS Holdings, LLC. |
| 2018-05-01 | Vystar acquired substantially all of the assets of UV Flu Technologies, Inc. |
| 2019-05-01 | Vystar acquired the assets of Fluid Energy Conversion Inc. |
| 2019-07-01 | Vystar acquired 58% of the outstanding shares of common stock of Murida Furniture Co., Inc. dba Rotmans Furniture. |
| 2019-07-22 | Steven Rotman's Employment agreement was dated. |
| 2020-12-01 | Vystar selected Corrie MacColl Limited as its exclusive global partner for Vytex. |
| 2022-04-11 | The Company amended its Articles of Incorporation to add the terms of a 10 % Series B Cumulative Convertible Preferred Stock. |
| 2022-07-08 | The Company amended its Articles of Incorporation to add the terms of a 10 % Series C Cumulative Convertible Preferred Stock. |
| 2022-12-14 | Rotmans closed its showroom. |
| 2023-12-21 | Steven Rotman resigned as CEO and Jamie Rotman was appointed as CEO. |
| 2023-12-31 | End of the fiscal year for the report. |
| 2024-01-04 | 34,838 shares of Convertible Preferred Stock Series B were converted into 348,380 shares of common stock. |
| 2024-01-01 | Jamie Rotman's Employment Agreement was made retroactive to this date. |
| 2024-06-01 | The Company entered into a term convertible promissory note with Blue Oar. |
| 2024-07-22 | The Company entered into an Employment Agreement with Ms. Jamie Rotman. |
| 2024-09-06 | Date of the report. |
Keywords
Vystar, Vytex, RxAir, Natural Rubber Latex, Air Purifiers, Financial Results, Net Loss, Revenue, Operating Expenses, Discontinued Operations, Going Concern, Intellectual Property, Medical Devices, Mattresses, Latex, Patents
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.